FDA Approved: REMERONSOLTAB — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA lists a supplemental application for REMERONSOLTAB (mirtazapine) submitted by Organon LLC, indicating an ongoing regulatory action for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• REMERONSOLTAB (Mirtazapine)

Snippet

SUPPL AP for REMERONSOLTAB (MIRTAZAPINE)